| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/2004 | US6762030 Complexing; immunoassay, immunotherapy |
| 07/13/2004 | US6762029 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6761910 Sublingually administering a drug with a bioadhesion or mucoadhesion promoting compound; water soluble carrier particles; effective plasma levels within a short time; fentanyl analgesic |
| 07/13/2004 | US6761909 Compressed antisolvent fluid precipitates particles; organic cosolvent system; biocompatible polymer for pulmonary sustained insulin release; inhalant powder; solvent extraction |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761894 Immune response against intracellular pathogens and in particular mycobacterium tuberculosis. |
| 07/13/2004 | US6761892 Heat shock protein-based vaccines and immunotherapies |
| 07/13/2004 | US6761891 Medicament for treating a manifested lyme disease |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | US6761882 Helical cytokine zalpha33 |
| 07/13/2004 | US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 07/13/2004 | CA2288913C Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/13/2004 | CA2155020C Antiviral naphthoquinone compounds, compositions and uses thereof |
| 07/13/2004 | CA2137748C Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants |
| 07/13/2004 | CA2134080C Natural humain igm antibodies |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056971A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/08/2004 | WO2004056965A2 Nucleic acids encoding antifungal drug targets and methods of use |
| 07/08/2004 | WO2004056876A1 Polypeptides with antiviral activity |
| 07/08/2004 | WO2004056871A2 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | WO2004056869A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | WO2004056866A1 Asthma susceptibility locus |
| 07/08/2004 | WO2004056865A2 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | WO2004056862A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | WO2004056861A2 Glycoisoforms of adiponectin and uses thereof |
| 07/08/2004 | WO2004056857A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 07/08/2004 | WO2004056856A1 Inactive transcription factor tif-ia and uses thereof |
| 07/08/2004 | WO2004056853A2 An immunomodulatory protein derived from trypanosomes and uses thereof |
| 07/08/2004 | WO2004056849A2 Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria |
| 07/08/2004 | WO2004056407A2 Biomedical devices with antimicrobial coatings |
| 07/08/2004 | WO2004056392A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| 07/08/2004 | WO2004056388A1 Methods of enhancing immune system function in a subject |
| 07/08/2004 | WO2004056387A1 Synthetic peptide analogs for the treatment of cancer |
| 07/08/2004 | WO2004056386A2 Nucleic acids involved in blood-brain barrier control |
| 07/08/2004 | WO2004056385A2 Modulation of activity of neurotrophins |
| 07/08/2004 | WO2004056384A2 Use of factor vii polypeptides for preventing formation of inhibitors to blood coagulation factor viii and ix |
| 07/08/2004 | WO2004056378A1 Means for preventing and curing endocrine system disturbances |
| 07/08/2004 | WO2004056347A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 07/08/2004 | WO2004056323A2 Method of treating angiogenic tissue growth |
| 07/08/2004 | WO2004056318A2 Method for treating amyloid disease |
| 07/08/2004 | WO2004056317A2 Compositions for the treatment and prevention of nephropathy |
| 07/08/2004 | WO2004056314A2 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
| 07/08/2004 | WO2004056313A2 Prevention and treatment of cardiac arrhythmias |
| 07/08/2004 | WO2004056310A2 Methods of diagnosis and treatment of interstitial lung disease |
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004056186A1 Cell-based vegf delivery |
| 07/08/2004 | WO2004044194A3 Calmodulin independent activation of nitric oxide synthase by nadph analogs |
| 07/08/2004 | WO2004042361A3 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 07/08/2004 | WO2004041179A3 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 07/08/2004 | WO2004041071A3 Compositions, systems, and methods for focusing a cell-mediated immune response |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004034966A3 Substances for preventing and treating autoimmune diseases |
| 07/08/2004 | WO2004033490A3 Hcmv derived immunomodulatory polypeptide |
| 07/08/2004 | WO2004031221A9 Tumor targeting agents and uses thereof |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004021995A3 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 07/08/2004 | WO2004019909A3 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 07/08/2004 | WO2004019866A3 Compositions and methods for treating cardiovascular disease |
| 07/08/2004 | WO2004018517A3 POLYPEPTIDE HAVING GnSAF ACTIVITY AND SYNTHETIC ANTIBODIES |
| 07/08/2004 | WO2004012759B1 Use of erythropoietin |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004009072B1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2004003170A3 Agents capable of inhibiting ras and uses thereof |
| 07/08/2004 | WO2004001027A8 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 07/08/2004 | WO2004001023A3 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 07/08/2004 | WO2003104277A3 Stat6 activation gene |
| 07/08/2004 | WO2003097687A3 Neuroprotective polypeptides and methods of use |
| 07/08/2004 | WO2003092598A3 Treatment for pompe disease |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003079746A3 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 07/08/2004 | WO2003072061A3 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003057012A3 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2003026591A9 Modification of feeding behavior |
| 07/08/2004 | WO2003024990A3 Variants of corticotropin releasing hormone receptor type 1 and uses thereof |
| 07/08/2004 | WO2003020297A8 Method of improving wound healing |
| 07/08/2004 | WO2003020245A8 Residual solvent extraction method and microparticles produced thereby |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133936 Comprises aphid myrosinase for use as an insecticidal agent when expressed in plants and an antitumor agent when expressed in mammals; biological pest control |
| 07/08/2004 | US20040133934 Transgenic animals that produce human hemoglobin |
| 07/08/2004 | US20040133932 Genetically engineered mammal for use as bioreactor in expression of heterologous proteins and blood coagulation factors in milk |
| 07/08/2004 | US20040133013 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 07/08/2004 | US20040132984 Oligonuclelotide sequences for use in controlling expression and translation of neutrophil gelatinase associated lipocalin (NGAL) and treatment and prevention of inflammatory bowel disease: RNA interference; gene expression inhibition |
| 07/08/2004 | US20040132977 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 07/08/2004 | US20040132974 Cell adhesion polypeptide for use tools in diagnosis, prevention and treatment of cardiovascular, cell proliferative, ischemic, restenotic, blood and gastrointestinal disorders |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132969 Amino acid sequences for use in the prevention and treatment of cell proliferative, arthritic, cardiovascular and skin disorders; antitumor agents; antiscarring agents; wound healing agents |
| 07/08/2004 | US20040132968 Novel bag proteins and nucleic acid molecules encoding them |
| 07/08/2004 | US20040132967 Mimetic peptide comprised of terminal amino acid sequences of surfactant protein b (SP-B) and dipalmitoylphosphatidylcholine for use in treatment of respiratory system disorder |
| 07/08/2004 | US20040132825 Methods of treating cancer with HDAC inhibitors |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |